nifedipine has been researched along with ceruletide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernhardt, L; Pieper, S; Porschen, R; Schade, B; Wienbeck, M | 1 |
| Celiński, K; Cichoz-Lach, H; Czerny, K; Kleinrok, Z; Słomka, M; Wargocki, J | 1 |
1 trial(s) available for nifedipine and ceruletide
| Article | Year |
|---|---|
In vivo effects of nifedipine and BAY 1 8201 on ceruletide induced gallbladder contraction.
Topics: Adult; Blood Pressure; Calcium Channel Blockers; Ceruletide; Clinical Trials as Topic; Gallbladder; Heart Rate; Humans; Male; Muscle Contraction; Nifedipine; Organic Chemicals; Random Allocation; Ultrasonography | 1988 |
1 other study(ies) available for nifedipine and ceruletide
| Article | Year |
|---|---|
The influence of nifedipine (calcium channel blocker) and Bay-K-8644 (calcium channel agonist) on the development of experimental acute pancreatitis.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Amylases; Animals; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Ceruletide; Cholecystokinin; Male; Nifedipine; Organ Size; Pancreas; Pancreatitis; Rats; Rats, Wistar; Second Messenger Systems | 2001 |